Logo image of V3V.DE

FAMICORD AG (V3V.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:V3V - DE000A0BL849 - Common Stock

5.45 EUR
+0.05 (+0.93%)
Last: 12/8/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to V3V. V3V was compared to 29 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of V3V have multiple concerns. V3V is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

V3V had positive earnings in the past year.
V3V had a positive operating cash flow in the past year.
In multiple years V3V reported negative net income over the last 5 years.
Of the past 5 years V3V 4 years had a positive operating cash flow.
V3V.DE Yearly Net Income VS EBIT VS OCF VS FCFV3V.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10M -20M

1.2 Ratios

V3V's Return On Assets of 1.61% is on the low side compared to the rest of the industry. V3V is outperformed by 65.52% of its industry peers.
V3V has a Return On Equity of 10.63%. This is comparable to the rest of the industry: V3V outperforms 55.17% of its industry peers.
Industry RankSector Rank
ROA 1.61%
ROE 10.63%
ROIC N/A
ROA(3y)-7.04%
ROA(5y)-3.48%
ROE(3y)-60.2%
ROE(5y)-34.49%
ROIC(3y)N/A
ROIC(5y)N/A
V3V.DE Yearly ROA, ROE, ROICV3V.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150

1.3 Margins

V3V has a Profit Margin of 3.20%. This is comparable to the rest of the industry: V3V outperforms 58.62% of its industry peers.
V3V's Gross Margin of 36.66% is fine compared to the rest of the industry. V3V outperforms 62.07% of its industry peers.
In the last couple of years the Gross Margin of V3V has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 3.2%
GM 36.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.67%
GM growth 5Y-8.9%
V3V.DE Yearly Profit, Operating, Gross MarginsV3V.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40

3

2. Health

2.1 Basic Checks

V3V does not have a ROIC to compare to the WACC, probably because it is not profitable.
V3V has more shares outstanding than it did 1 year ago.
V3V has more shares outstanding than it did 5 years ago.
The debt/assets ratio for V3V has been reduced compared to a year ago.
V3V.DE Yearly Shares OutstandingV3V.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
V3V.DE Yearly Total Debt VS Total AssetsV3V.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

V3V has an Altman-Z score of 0.56. This is a bad value and indicates that V3V is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.56, V3V is not doing good in the industry: 82.76% of the companies in the same industry are doing better.
The Debt to FCF ratio of V3V is 2.09, which is a good value as it means it would take V3V, 2.09 years of fcf income to pay off all of its debts.
V3V's Debt to FCF ratio of 2.09 is amongst the best of the industry. V3V outperforms 96.55% of its industry peers.
A Debt/Equity ratio of 0.56 indicates that V3V is somewhat dependend on debt financing.
V3V has a better Debt to Equity ratio (0.56) than 86.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 2.09
Altman-Z 0.56
ROIC/WACCN/A
WACC6.32%
V3V.DE Yearly LT Debt VS Equity VS FCFV3V.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M 30M 40M

2.3 Liquidity

V3V has a Current Ratio of 0.76. This is a bad value and indicates that V3V is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of V3V (0.76) is worse than 72.41% of its industry peers.
A Quick Ratio of 0.70 indicates that V3V may have some problems paying its short term obligations.
V3V's Quick ratio of 0.70 is in line compared to the rest of the industry. V3V outperforms 44.83% of its industry peers.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.7
V3V.DE Yearly Current Assets VS Current LiabilitesV3V.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 109.51% over the past year.
The Revenue has been growing slightly by 7.73% in the past year.
Measured over the past years, V3V shows a very strong growth in Revenue. The Revenue has been growing by 30.44% on average per year.
EPS 1Y (TTM)109.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%160%
Revenue 1Y (TTM)7.73%
Revenue growth 3Y57.65%
Revenue growth 5Y30.44%
Sales Q2Q%8.91%

3.2 Future

The Earnings Per Share is expected to grow by 30.68% on average over the next years. This is a very strong growth
V3V is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.88% yearly.
EPS Next Y58.33%
EPS Next 2Y38.44%
EPS Next 3Y34.2%
EPS Next 5Y30.68%
Revenue Next Year9.33%
Revenue Next 2Y8.01%
Revenue Next 3Y7.82%
Revenue Next 5Y2.88%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
V3V.DE Yearly Revenue VS EstimatesV3V.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M
V3V.DE Yearly EPS VS EstimatesV3V.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 38.93, the valuation of V3V can be described as expensive.
75.86% of the companies in the same industry are cheaper than V3V, based on the Price/Earnings ratio.
V3V is valuated rather expensively when we compare the Price/Earnings ratio to 26.34, which is the current average of the S&P500 Index.
The Forward Price/Earnings Ratio is negative for V3V. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 38.93
Fwd PE N/A
V3V.DE Price Earnings VS Forward Price EarningsV3V.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300 -400 -500

4.2 Price Multiples

68.97% of the companies in the same industry are cheaper than V3V, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, V3V is valued a bit cheaper than 65.52% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.71
EV/EBITDA 11.44
V3V.DE Per share dataV3V.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
V3V's earnings are expected to grow with 34.20% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.67
PEG (5Y)N/A
EPS Next 2Y38.44%
EPS Next 3Y34.2%

0

5. Dividend

5.1 Amount

V3V does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

FAMICORD AG

FRA:V3V (12/8/2025, 7:00:00 PM)

5.45

+0.05 (+0.93%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-21 2025-11-21
Earnings (Next)04-28 2026-04-28
Inst Owners9.87%
Inst Owner ChangeN/A
Ins Owners58.45%
Ins Owner ChangeN/A
Market Cap96.14M
Revenue(TTM)80.64M
Net Income(TTM)2.58M
Analysts45.71
Price Target7.65 (40.37%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)15.38%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 38.93
Fwd PE N/A
P/S 1.19
P/FCF 10.71
P/OCF 7.94
P/B 3.96
P/tB N/A
EV/EBITDA 11.44
EPS(TTM)0.14
EY2.57%
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)0.51
FCFY9.34%
OCF(TTM)0.69
OCFY12.6%
SpS4.57
BVpS1.38
TBVpS-1.68
PEG (NY)0.67
PEG (5Y)N/A
Graham Number2.08
Profitability
Industry RankSector Rank
ROA 1.61%
ROE 10.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3.2%
GM 36.66%
FCFM 11.13%
ROA(3y)-7.04%
ROA(5y)-3.48%
ROE(3y)-60.2%
ROE(5y)-34.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.67%
GM growth 5Y-8.9%
F-Score7
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 2.09
Debt/EBITDA 1.65
Cap/Depr 35.61%
Cap/Sales 3.89%
Interest Coverage N/A
Cash Conversion 147.25%
Profit Quality 347.6%
Current Ratio 0.76
Quick Ratio 0.7
Altman-Z 0.56
F-Score7
WACC6.32%
ROIC/WACCN/A
Cap/Depr(3y)60.39%
Cap/Depr(5y)47.49%
Cap/Sales(3y)7.53%
Cap/Sales(5y)6.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)109.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%160%
EPS Next Y58.33%
EPS Next 2Y38.44%
EPS Next 3Y34.2%
EPS Next 5Y30.68%
Revenue 1Y (TTM)7.73%
Revenue growth 3Y57.65%
Revenue growth 5Y30.44%
Sales Q2Q%8.91%
Revenue Next Year9.33%
Revenue Next 2Y8.01%
Revenue Next 3Y7.82%
Revenue Next 5Y2.88%
EBIT growth 1Y97.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year562.86%
EBIT Next 3Y110.83%
EBIT Next 5Y79.58%
FCF growth 1Y198.46%
FCF growth 3Y20.6%
FCF growth 5Y6%
OCF growth 1Y520.19%
OCF growth 3Y37.37%
OCF growth 5Y14.78%

FAMICORD AG / V3V.DE FAQ

What is the ChartMill fundamental rating of FAMICORD AG (V3V.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to V3V.DE.


What is the valuation status for V3V stock?

ChartMill assigns a valuation rating of 3 / 10 to FAMICORD AG (V3V.DE). This can be considered as Overvalued.


What is the profitability of V3V stock?

FAMICORD AG (V3V.DE) has a profitability rating of 2 / 10.


What is the financial health of FAMICORD AG (V3V.DE) stock?

The financial health rating of FAMICORD AG (V3V.DE) is 3 / 10.